Methylprednisolone (Depo-medrol, Medrol, Solu-medrol)
Methylprednisolone
Pfizer Laboratories (Pty) Ltd
Registration
- Applicant
- Pfizer Laboratories (Pty) Ltd
- Registrations
- 4
- Schedule source
- Consolidated Schedules 06 July 2026
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Depo-medrol 40 MG EACH 1,0 ml SUSPENSION CONTAINS METHYLPREDNISOLONE ACETATE A 40,0 mg | 40 mg | C0726 | Old Medicine | S4 | None |
| Medrol 16 MG EACH TABLET CONTAINS METHYLPREDNISOLONE A 16,0 mg | 16 mg | C0728 | Old Medicine | S4 | None |
| Solu-medrol 40 MG EACH VIAL CONTAINS METHYLPREDNISOLONE SODIUM SUCCINATE EQUIVALENT TO 40 mg METHYLPREDNISOLONE | 40 mg | D0135D/21.5./135 | Registered | S4 | None |
| Solu-medrol 125 EACH VIAL CONTAINS METHYLPREDNISOLONE SODIUM SUCCINATE EQUIVALENT TO 125 mg METHYLPREDNISOLONE | 125 | D0136D/21.5.1/136 | Registered | S4 | None |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Methylprednisolone acetate
S4: Methylprednisolone
Consolidated Schedules 06 July 2026, line 7098
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
[2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-Dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate
Drag to rotate. Structure from PubChem CID 5877.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.